Avian influenza vaccine immunity
Phase 1
Recruiting
- Conditions
- Avian influenza and seasonal influenzaTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- CTIS2023-509178-44-00
- Lead Sponsor
- Finnish Institute For Health And Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Age 18 to 65 years, Belongs to the target group of the avian influenza vaccine, Is planning to receive at least one dose of the avian influenza vaccine, Is able to understand the given written and oral information, Has given written informed consent, Home address in Finland, Is able to give samples 3 weeks after each vaccine dose and preferably also participate in the follow-up at 6 and 12 months, Pregnant and lactating women can participate in the study
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method